Helsinki, 20 December 2024 - ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR) AFARAK GROUP SE´S 2025 FINANCIAL ...

Novo Nordisk has told the world it expects patients to lose “at least 25%” of their body weight on its experimental drug CagriSema. On Friday, Novo released the results of a large Phase 3 trial of the ...

Transforming Patient Care, Diagnostics, and Drug Development, Generative AI in Healthcare Emerges as a Game-Changer in Global Healthcare Systems.Pune, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Generative AI ...